Skip to main content
. 2020 Apr 21;13:59. doi: 10.3389/fnmol.2020.00059

TABLE 5.

Summary of LAMA2-CMD mice lacking other genes.

Approach Deletion Mouse model Muscle condition and overall health References
Extracellular matrix and receptor modulation Integrin α7 dy3K/dy3K No difference Gawlik and Durbeej, 2015
Dystrophin dy3K/dy3K Worsened Gawlik et al., 2014
β-sarcoglycan dy3K/dy3K Worsened Gawlik et al., 2014
Laminin α4 dy3K/dy3K Overall phenotype worsened but skeletal muscle condition remains to be reported Miner et al., 2004
dy2J/dy2J
Apoptosis inhibition Bax dyW/dyW Improved Girgenrath et al., 2004
Modulation mitochondrial permeability transition Cyclophilin D dyW/dyW Improved Millay et al., 2008
Inflammation and fibrosis modulation Complement C3 dy/dy Improved Connolly et al., 2002
Galectin-3 dy3K/dy3K No difference Gawlik et al., 2017
Osteopontin dy3K/dy3K Slightly worsened Gawlik et al., 2017
miR-21 dy3K/dy3K No difference Moreira Soares Oliveira et al., 2017
dy2J/dy2J No difference
Muscle growth Myostatin dyW/dyW No difference Li et al., 2005